Pharma stocks have gained investor interest as the Nifty Pharma index reaches new highs. Amid economic uncertainties, defensive sectors like pharma offer minimal risk. Notable picks include Lupin, Sun Pharma, and Dr Reddy’s. The sector saw significant foreign inflows, driven by the performance of the generic drug Revlimid.
Mark Mobius, pioneer of emerging markets investing, dies at 89
Mark Mobius, a pioneer of emerging markets investing, has died at 89. Known for decades at Franklin Templeton Investments, he championed opportunities across developing economies,
April 15, 2026